Does ENZALUTAMIDE Cause Tenderness? 16 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Tenderness have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.
16
Reports of Tenderness with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
3
Deaths
2
Hospitalizations
How Dangerous Is Tenderness From ENZALUTAMIDE?
Of the 16 reports, 3 (18.8%) resulted in death, 2 (12.5%) required hospitalization.
Is Tenderness Listed in the Official Label?
Yes, Tenderness is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Tenderness?
METHOTREXATE (853)
ETANERCEPT (615)
TOFACITINIB (604)
ADALIMUMAB (561)
SECUKINUMAB (484)
SULFASALAZINE (294)
HYDROXYCHLOROQUINE (289)
PREDNISONE (278)
RITUXIMAB (262)
DICLOFENAC (258)
Which ENZALUTAMIDE Alternatives Have Lower Tenderness Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE